Swayze Eric — SEC insider filings
SEC reporting owner CIK 1791058. 44 insider filings on record with FilingPulse; latest filed 2026-10-19.
Transaction summary — filings shown
Covers all 44 filings on record, filed 2020-09-02 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 33 legs across 25 filings — 177,365 shares, $11,165,529 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 77.
- Largest priced transaction: sale of 18,338 shares @ $79.27 ($1,453,653) in IONIS PHARMACEUTICALS INC, filed 2026-01-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC (IONS) | EVP Research | 44 | — | 33 legs · 177,365 sh · $11,165,529 | 77 |
Insider filings — Swayze Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 125 @ $0 · Sale (S): 53 @ $43.54 · Option exercise (M): 125 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,602 @ $79.18 | EDGAR |
| 2026-03-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 256 @ $48.87 | EDGAR |
| 2026-02-13 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 9,435 @ $81.56 · Sale (S): 6,207 @ $82.07 | EDGAR |
| 2026-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,991 @ $0 · Sale (S): 6,179 @ $82.93 | EDGAR |
| 2026-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 21,366 @ $0 · Sale (S): 9,884 @ $75.34 · Option exercise (M): 111 @ $0 · Sale (S): 49 @ $75.97 · Grant/award (A): 25,800 (derivative) @ $0 · Option exercise (M): 21,366 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,125 @ $60.89 · Sale (S): 5,125 @ $78.57 · Option exercise (M): 18,338 @ $60.89 · Sale (S): 18,338 @ $79.27 · Option exercise (M): 5,125 (derivative) @ $0 · Option exercise (M): 18,338 (derivative) @ $0 · +2 more | EDGAR |
| 2025-10-16 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 125 @ $0 · Sale (S): 53 @ $73.62 · Option exercise (M): 125 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 6,849 @ $69.02 | EDGAR |
| 2025-10-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 14,142 @ $53.77 · Sale (S): 14,142 @ $66.09 · Option exercise (M): 12,972 @ $53.77 · Sale (S): 12,972 @ $66.23 · Option exercise (M): 14,142 (derivative) @ $0 · Option exercise (M): 12,972 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,000 @ $49.22 · Sale (S): 1,130 @ $53.68 | EDGAR |
| 2025-03-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 415 @ $28.21 | EDGAR |
| 2025-02-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 3,714 @ $0 · Sale (S): 1,367 @ $32.31 | EDGAR |
| 2025-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 19,111 @ $0 · Sale (S): 7,154 @ $32.84 · Option exercise (M): 49 @ $0 · Sale (S): 22 @ $32.70 · Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 33,000 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 163 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,194 @ $37.92 | EDGAR |
| 2024-10-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 125 @ $0 · Sale (S): 53 @ $38.31 · Option exercise (M): 125 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4/A | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1,940 @ $49.56 | EDGAR |
| 2024-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 11 @ $38.64 | EDGAR |
| 2024-03-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 605 @ $34.42 | EDGAR |
| 2024-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,773 @ $52 · Grant/award (A): 3,715 @ $0 · Sale (S): 1,907 @ $49.56 | EDGAR |
| 2024-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 17,069 @ $0 · Sale (S): 6,296 @ $50.42 · Option exercise (M): 21 @ $0 · Sale (S): 9 @ $50.42 · Option exercise (M): 17,069 (derivative) @ $0 · Option exercise (M): 21 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 17,000 (derivative) @ $0 · Grant/award (A): 20,400 (derivative) @ $0 · Grant/award (A): 116 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 27,200 (derivative) @ $0 · Grant/award (A): 154 (derivative) @ $0 | EDGAR |
| 2024-01-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 27,100 @ $47.34 · Sale (S): 27,100 @ $50.19 · Option exercise (M): 27,100 (derivative) @ $0 | EDGAR |
| 2023-10-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 125 @ $0 · Sale (S): 52 @ $47.95 · Option exercise (M): 125 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 575 @ $30.52 | EDGAR |
| 2023-02-07 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 3,715 @ $0 · Sale (S): 1,815 @ $40.79 | EDGAR |
| 2023-01-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 15,780 @ $0 · Sale (S): 5,631 @ $39.74 · Option exercise (M): 15,780 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 14,338 (derivative) @ $0 · Grant/award (A): 17,207 (derivative) @ $0 · Grant/award (A): 81 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 22,942 (derivative) @ $0 · Grant/award (A): 108 (derivative) @ $0 | EDGAR |
| 2022-10-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 500 (derivative) @ $0 | EDGAR |
| 2022-09-21 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 1,000 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 460 @ $44.55 | EDGAR |
| 2022-08-09 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 1 @ $45.20 | EDGAR |
| 2022-04-25 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 378 @ $44.15 | EDGAR |
| 2022-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 621 @ $28.37 | EDGAR |
| 2022-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 13,809 @ $0 · Tax withholding (F): 4,994 @ $30.12 · Option exercise (M): 13,809 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,144 (derivative) @ $0 · Grant/award (A): 14,859 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 29,718 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 460 @ $44.54 | EDGAR |
| 2021-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 8,944 @ $0 · Tax withholding (F): 3,216 @ $61.28 · Grant/award (A): 23,976 (derivative) @ $0 · Option exercise (M): 8,944 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 195 @ $55.99 · Grant/award (A): 53,945 (derivative) @ $0 | EDGAR |
| 2020-09-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Other (J): 1 @ $44.45 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791058 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs